Document is current
Any future updates will be listed below
-
Authors
Wekenborg, Magdalena Katharina
Gilbert, Stephen
Kather, Jakob Nikolas
- License Information
-
More Information
Article History
Received: 4 January 2025
Accepted: 10 March 2025
First Online: 19 March 2025
Competing interests
: M.K.W. declares no competing interests. S.G. declares a nonfinancial interest as an Advisory Group member of the EY-coordinated “Study on Regulatory Governance and Innovation in the field of Medical Devices” conducted on behalf of the DG SANTE of the European Commission. S.G. declares the following competing financial interests: he has or has had consulting relationships with Una Health GmbH, Lindus Health Ltd., Flo Ltd, ICURA ApS, Rock Health Inc., Thymia Ltd., FORUM Institut für Management GmbH, High-Tech Gründerfonds Management GmbH, DG SANTE, Prova Health Ltd and Ada Health GmbH and holds share options in Ada Health GmbH. S.G. is a News and Views Editor for npj Digital Medicine. S.G. played no role in the internal review or decision to publish this article. J.N.K. declares consulting services for Bioptimus, France; Owkin, France; DoMore Diagnostics, Norway; Panakeia, UK; AstraZeneca, UK; Mindpeak, Germany; and MultiplexDx, Slovakia. Furthermore, he holds shares in StratifAI GmbH, Germany, Synagen GmbH, Germany, and has received a research grant by GSK, and has received honoraria by AstraZeneca, Bayer, Daiichi Sankyo, Janssen, Merck, MSD, BMS, Roche, Pfizer and Fresenius.
